Investors of the project "Voronezhmedsteklo" for 3.5 billion rubles are counting on 10% growth in the Russian market

Guide the investment project "Voronezhmedsteklo" for the production of glass and glass products for the pharmaceutical business expects that the growth of the market at the time of start-up company will be 10-12% per year. These data are presented in the annual report of the company.

Describing the current state of the market, the compilers of the report wrote that "only few in about 10 - an obvious tendency to reduce them as consumers demand from your presence at it full production cycle." In "Voronezhmedstekle" believe that all large consumers will conduct an audit of their supplying the glass industry, "according to the rules of GMP and ISO in the field of safety and quality."

It is noteworthy that the prospects for the pharmaceutical industry, which depends on the development of the enterprise, "Voronezhmedstekle" estimate on the order of Industry and Trade, dated October 2009. The paper provides a perspective on the scope to 2020: annual market growth of 10-12%. In addition to 8 times should increase exports of Russian medicine.

"Voronezhmedsteklo" (JSC "MC-Voronezh") - an investment project, claimed to be implemented in the industrial park (IP) "Maslowski." In March of this year, representatives of the company rented SP 20 hectares of land for the construction of a plant for the production of flat glass, fiber glass and hollow glass for $ 3.5 billion. Construction of the object is to begin in 2015.